Aura Biosciences, Inc.
NASDAQ:AURA
9.55 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 1.295 | 1.177 | 0.835 | 0.831 | 0.509 |
| Gross Profit
| -1.295 | -1.177 | -0.835 | -0.831 | -0.509 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 63.937 | 42.238 | 25.161 | 18.042 | 19.617 |
| General & Administrative Expenses
| 19.759 | 18.057 | 10.089 | 4.164 | 4.523 |
| Selling & Marketing Expenses
| 19.739 | 0 | 0 | 0 | 0 |
| SG&A
| 19.759 | 18.057 | 10.089 | 4.164 | 4.523 |
| Other Expenses
| 0 | -0.005 | -0.011 | 0.003 | -0.044 |
| Operating Expenses
| 83.696 | 60.295 | 35.25 | 22.206 | 24.14 |
| Operating Income
| -84.991 | -60.295 | -35.25 | -22.206 | -24.14 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 8.72 | 1.532 | -0.001 | 0.003 | -0.06 |
| Income Before Tax
| -76.271 | -58.763 | -35.251 | -22.206 | -24.2 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.137 | -1.532 | -0.83 | 0.003 | 0.005 |
| Net Income
| -76.408 | -57.231 | -34.421 | -22.209 | -24.205 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 |
| EPS
| -1.93 | -1.91 | -1.18 | -0.76 | -0.83 |
| EPS Diluted
| -1.93 | -1.91 | -1.18 | -0.76 | -0.83 |
| EBITDA
| -83.696 | -59.968 | -35.236 | -21.375 | -23.631 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 |